NCT04897581

Brief Summary

This clinical study aims to compare the efficacy of two brief psychological interventions: Brief Behavioral Therapy for Insomnia (BBIT) and Physical Self-Regulation or (PSR) delivered over telehealth for the management of chronic musculoskeletal orofacial pain conditions (local myalgia, myofascial pain, centrally mediated myalgia) in a tertiary orofacial pain clinic. It is hypothesized that both interventions will produce beneficial changes and exploratory analysis will aim to establish which intervention -if any- is better for each specific outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 21, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

October 21, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2023

Completed
Last Updated

June 6, 2023

Status Verified

May 1, 2023

Enrollment Period

1.6 years

First QC Date

May 14, 2021

Last Update Submit

June 2, 2023

Conditions

Keywords

local myalgiacentrally-mediated myalgiamasticatory painsleepinsomniabehavioral therapyself-regulationdepressionanxietyfatigue

Outcome Measures

Primary Outcomes (3)

  • Change in Self-report Insomnia Symptoms

    Insomnia symptomatology will be assessed via the Insomnia Severity Index (ISI). The ISI includes seven items (sleep-onset, sleep maintenance, early morning awakening, satisfaction with current sleep pattern, interference with daily functioning, impairment attributed to sleep problems, distress caused by sleep problems), related to the prior 2 weeks on a five-point Likers scale (0= no problem, 4 = severe problem). The total score ranges from 0 to 28, with 28 indicating severe insomnia. The cut-off for the present study is 15. The ISI has good internal consistency and is demonstrated to be sensitive to changes in sleep of older adults following behavioral treatment for insomnia. Clinical improvement is defined as a reduction of ISI below the cut-off of 15.

    At pre-intervention (1 week before starting with the intervention) and post-intervention (2 weeks after the last session of the intervention)

  • Change in Self-report Average Pain Intensity

    The average pain intensity will be assessed using a Numeric Rating Scale (NRS) on a 10-point scale, where 0 coincides with "no pain" and 10 coincides with "worse pain ever felt".

    At pre-intervention (1 week before starting with the intervention), post-intervention (2 weeks after the last session of the intervention)

  • Change in Self-report Quality of Life

    The overall quality of life will be assessed with 12-Item Short Form Health Survey (SF-12), a 12-item questionnaire designed to measure general health by addressing eight domains: limitations in social, physical, usual role activities because of physical health and emotional problems; bodily pain; general mental health; vitality; general health perceptions. SF-12 has been shown to reflect change over time like the long form SF-36 and to demonstrate good reliability and validity . Studies have addressed the impact of orofacial pain and sleep problems on health-related quality of life. The average score of the US population is set at 50. A score below this cut-off identifies a poor self-report quality of life.

    At pre-intervention (1 week before starting with the intervention), post-intervention (2 weeks after the last session of the intervention)

Secondary Outcomes (6)

  • Change in Self-report Sleep Quality

    At pre-intervention (1 week before starting with the intervention), post-intervention (2 weeks after the last session of the intervention)

  • Sleep architecture

    Each morning and each evening from the first session to 2 weeks after the last session of the intervention

  • Change in Self-report Depression Symptoms

    At pre-intervention (one week before the first session of the intervention), at post-intervention (two weeks after the last session of the intervention) and every day during the intervention period

  • Change in Self-report Anxiety Symptoms

    At pre-intervention (one week before the first session of the intervention), at post-intervention (two weeks after the last session of the intervention) and every day during the intervention period

  • Change in Self-report Headache Intensity

    At pre-intervention (one week before the first session of the intervention), at post-intervention (two weeks after the last session of the intervention)

  • +1 more secondary outcomes

Study Arms (2)

Brief Behavioral Therapy for Insomnia, BBTI

EXPERIMENTAL

Participants in this group will receive 3 sessions of BBTI over telehealth.

Behavioral: Brief Behavioral Therapy for Insomnia, BBTI

Physical Self-Regulation, PSR

EXPERIMENTAL

Participants in this group will receive 3 sessions of PSR over telehealth.

Behavioral: Physical Self-Regulation, PSR

Interventions

BBTI includes sleep hygiene, stimulus control, and sleep restriction, and is administered in three 50-minute sessions over telehealth by psychologic team.

Brief Behavioral Therapy for Insomnia, BBTI

PSR is conducted over telehealth and consists of three 50-minute sessions focused on jaw relaxation exercises, proprioceptive awareness training, and diaphragmatic breathing entrainment.

Physical Self-Regulation, PSR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • present with a score on Insomnia Severity Index \> 15
  • have a primary diagnosis of chronic (onset more than 3 months before) MSK pain (myofascial pain and/or local myalgia and/or centrally mediated myalgia) from a board-certified orofacial pain specialist at UK Orofacial Pain Clinic
  • maintain a stable medication regime in previous month and during the intervention
  • older than 18 years old
  • able to understand English
  • willing to participate to telehealth intervention
  • have internet access and an email address
  • present with total STOP BANG score \< 5

You may not qualify if:

  • less than 18 years old
  • unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40536, United States

Location

Related Publications (1)

  • Ballou S, Katon J, Rangan V, Cheng V, Nee J, Iturrino J, Lembo A. Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig Dis Sci. 2020 Nov;65(11):3260-3270. doi: 10.1007/s10620-020-06182-w. Epub 2020 Mar 9.

    PMID: 32152868BACKGROUND

MeSH Terms

Conditions

MyalgiaSleep Initiation and Maintenance DisordersSelf-ControlDepressionAnxiety DisordersFatigue

Interventions

phosphatidylserine receptor

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersMental DisordersSocial BehaviorBehaviorBehavioral Symptoms

Study Officials

  • Ian Boggero, PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Data will be coded such that the Principal Investigator (PI) analyzing the data will be blind to conditions to prevent bias during the data collection and analysis. Also, the PI will remain blind through the study and will not provide either of the interventions. The statistician will be blind. The examiner will collect the data after de-identification of the sensitive and identifiable data.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 14, 2021

First Posted

May 21, 2021

Study Start

October 21, 2021

Primary Completion

May 23, 2023

Study Completion

May 23, 2023

Last Updated

June 6, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

The data will be de-identified from the sensible data information. The data will be retained for 5 years after the end of the study. There is no intension to share the IPD with other researchers. However, the data collected from this study will be utilised by the investigators for possible future studies.

Locations